New York to Start Antibody Testing from April 20
IndraStra Global

New York to Start Antibody Testing from April 20

By IndraStra Global News Team

New York to Start Antibody Testing from April 20

On April 19, 2020, the Governor of New York state, Andrew Cuomo announced that his state is set to roll out antibody testing to survey the state's population and determine how many people have been exposed to novel coronavirus. 

He also informed the public that it appears, the state has passed its peak in coronavirus fatalities as the death toll (across the state) dropped for a second consecutive day.  According to the latest figures, Cuomo announced that 507 people died from COVID-19 on Saturday, down 43 from the day before. 

Unlike polymerase chain reaction (PCR) tests (also referred to as molecular or nucleic acid-based tests), antibody tests aren’t intended to identify active SARS-CoV-2 infections. Instead of detecting viral genetic material in the throat or nasal swabs, antibody tests reveal markers of immune response— the IgM and IgG antibodies that for most people show up in blood more than a week after they start to feel sick, when symptoms may already be waning.

Image Attribute: Antibody test kit, photo by Jens Meyer / Source: AP Images

Image Attribute: Antibody test kit, photo by Jens Meyer / Source: AP Images

Additionally, the test can support priority screening of high-risk groups, such as healthcare workers, food supply workers who might already have developed a certain level of immunity and can continue serving and/or return to work. 

IMPORTANT NOTE:

On April 17, 2020, The World Health Organization warned that coronavirus antibody tests are basically useless when it comes to proving immunity. So-called “serological” tests can only show if antibodies are present in a person’s blood and it only indicates if a person has had COVID-19, either with or without symptoms the WHO said in a statement.

And, according to U.S Food and Drug Administration (FDA) Commissioner Stephen M. Hahn, MD, "while these tests can detect the body’s immune response to the virus, they should not be used for the sole purpose of diagnosing COVID-19 infection, as they do not detect the virus itself. Serological tests are beneficial in that they can help determine who no longer is susceptible to the infection as well as who may be a candidate for convalescent plasma donation."

IndraStra Global is now available on
Apple NewsGoogle News, Flipboard, Feedburner, and Telegram